{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:55:40Z","timestamp":1788972940321,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-026-01257-4","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T23:04:53Z","timestamp":1779491093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploration of Colonic Mucus as A Dissolution Compartment for Orally Administered Drugs"],"prefix":"10.1208","volume":"28","author":[{"given":"Mingjun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8917-2612","authenticated-orcid":false,"given":"Christel A. S.","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"1257_CR1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-023-00865-8","volume":"25","author":"K Raines","year":"2023","unstructured":"Raines K, et al. Drug dissolution in oral drug absorption: workshop report. AAPS J. 2023;25:103. https:\/\/doi.org\/10.1208\/s12248-023-00865-8.","journal-title":"AAPS J"},{"key":"1257_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/bdd.2510160502","volume":"16","author":"TT Kararli","year":"1995","unstructured":"Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos. 1995;16:351\u201380. https:\/\/doi.org\/10.1002\/bdd.2510160502.","journal-title":"Biopharm Drug Dispos"},{"key":"1257_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3109\/00365521.2014.898326","volume":"49","author":"HF Helander","year":"2014","unstructured":"Helander HF, Fandriks L. Surface area of the digestive tract - revisited. Scand J Gastroenterol. 2014;49:681\u20139. https:\/\/doi.org\/10.3109\/00365521.2014.898326.","journal-title":"Scand J Gastroenterol"},{"key":"1257_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020161","author":"G Lemmens","year":"2021","unstructured":"Lemmens G, Van Camp A, Kourula S, Van uytsel T, Augustijns P. Drug disposition in the lower gastrointestinal tract: targeting and monitoring. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13020161.","journal-title":"Pharmaceutics"},{"key":"1257_CR5","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1021\/acs.molpharmaceut.7b00095","volume":"14","author":"K Murray","year":"2017","unstructured":"Murray K, et al. Magnetic resonance imaging quantification of fasted state colonic liquid pockets in healthy humans. Mol Pharm. 2017;14:2629\u201338. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00095.","journal-title":"Mol Pharm"},{"key":"1257_CR6","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1111\/j.1365-2036.2005.02683.x","volume":"22","author":"C Schiller","year":"2005","unstructured":"Schiller C, et al. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther. 2005;22:971\u20139. https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02683.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"1257_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13400","volume":"30","author":"G Major","year":"2018","unstructured":"Major G, et al. Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging. Neurogastroenterol Motil. 2018;30:e13400. https:\/\/doi.org\/10.1111\/nmo.13400.","journal-title":"Neurogastroenterol Motil"},{"key":"1257_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13101729","author":"J Goelen","year":"2021","unstructured":"Goelen J, et al. Quantification of fluid volume and distribution in the paediatric colon via Magnetic Resonance Imaging. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13101729.","journal-title":"Pharmaceutics"},{"key":"1257_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1021\/mp800261a","volume":"6","author":"C Tannergren","year":"2009","unstructured":"Tannergren C, Bergendal A, Lennernas H, Abrahamsson B. Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment. Mol Pharm. 2009;6:60\u201373. https:\/\/doi.org\/10.1021\/mp800261a.","journal-title":"Mol Pharm"},{"key":"1257_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijpharm.2013.05.040","volume":"453","author":"HH Sigurdsson","year":"2013","unstructured":"Sigurdsson HH, Kirch J, Lehr CM. Mucus as a barrier to lipophilic drugs. Int J Pharm. 2013;453:56\u201364. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.05.040.","journal-title":"Int J Pharm"},{"key":"1257_CR11","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1007\/s13346-024-01574-1","volume":"14","author":"M Klitgaard","year":"2024","unstructured":"Klitgaard M, Jacobsen J, Kristensen MN, Berthelsen R, Mullertz A. Characterizing interregional differences in the rheological properties and composition of rat small intestinal mucus. Drug Deliv Transl Res. 2024;14:3309\u201320. https:\/\/doi.org\/10.1007\/s13346-024-01574-1.","journal-title":"Drug Deliv Transl Res"},{"key":"1257_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jconrel.2018.11.023","volume":"296","author":"YY Yeap","year":"2019","unstructured":"Yeap YY, et al. Intestinal mucus is capable of stabilizing supersaturation of poorly water-soluble drugs. J Control Release. 2019;296:107\u201313. https:\/\/doi.org\/10.1016\/j.jconrel.2018.11.023.","journal-title":"J Control Release"},{"key":"1257_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/jphp.12912","volume":"71","author":"LJ Henze","year":"2019","unstructured":"Henze LJ, et al. The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review. J Pharm Pharmacol. 2019;71:581\u2013602. https:\/\/doi.org\/10.1111\/jphp.12912.","journal-title":"J Pharm Pharmacol"},{"key":"1257_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejpb.2021.10.008","volume":"169","author":"V Barmpatsalou","year":"2021","unstructured":"Barmpatsalou V, et al. Physiological properties, composition and structural profiling of porcine gastrointestinal mucus. Eur J Pharm Biopharm. 2021;169:156\u201367. https:\/\/doi.org\/10.1016\/j.ejpb.2021.10.008.","journal-title":"Eur J Pharm Biopharm"},{"key":"1257_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ejpb.2014.01.001","volume":"87","author":"M Boegh","year":"2014","unstructured":"Boegh M, Baldursdottir SG, Mullertz A, Nielsen HM. Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption. Eur J Pharm Biopharm. 2014;87:227\u201335. https:\/\/doi.org\/10.1016\/j.ejpb.2014.01.001.","journal-title":"Eur J Pharm Biopharm"},{"key":"1257_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1023\/a:1011948703571","volume":"15","author":"AW Larhed","year":"1998","unstructured":"Larhed AW, Artursson P, Bjork E. The influence of intestinal mucus components on the diffusion of drugs. Pharm Res. 1998;15:66\u201371. https:\/\/doi.org\/10.1023\/a:1011948703571.","journal-title":"Pharm Res"},{"issue":"7","key":"1257_CR17","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1021\/acs.molpharmaceut.5c00298","volume":"22","author":"M Tjakra","year":"2025","unstructured":"Tjakra M, et al. Optimized artificial colonic mucus enabling physiologically relevant diffusion studies of drugs, particles, and delivery systems. Mol Pharm. 2025;22(7):4032\u201345. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c00298.","journal-title":"Mol Pharm"},{"key":"1257_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106361","volume":"181","author":"V Barmpatsalou","year":"2023","unstructured":"Barmpatsalou V, et al. Development and validation of a porcine artificial colonic mucus model reflecting the properties of native colonic mucus in pigs. Eur J Pharm Sci. 2023;181:106361. https:\/\/doi.org\/10.1016\/j.ejps.2022.106361.","journal-title":"Eur J Pharm Sci"},{"key":"1257_CR19","unstructured":"RDKit: Open-Source Cheminformatics (Version 2024.09.3). https:\/\/www.rdkit.org. Accessed 13 Dec 2024"},{"key":"1257_CR20","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ijpharm.2014.12.003","volume":"478","author":"BK Ahuja","year":"2015","unstructured":"Ahuja BK, Jena SK, Paidi SK, Bagri S, Suresh S. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension. Int J Pharm. 2015;478:540\u201352. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.12.003.","journal-title":"Int J Pharm"},{"key":"1257_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/bf00321579","volume":"340","author":"N Sistovaris","year":"1991","unstructured":"Sistovaris N, Hamachi Y, Kuriki T. Multifunctional substances\u202f? Determination of pKa-values by various methods. Fresenius J Anal Chem. 1991;340:345\u20139. https:\/\/doi.org\/10.1007\/bf00321579.","journal-title":"Fresenius J Anal Chem"},{"key":"1257_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15061735","author":"RM Leon","year":"2023","unstructured":"Leon RM, Issa MG, Duque MD, Daniel JSP, Ferraz HG. Development of a discriminative dissolution method, using in-silico tool for hydrochlorothiazide and valsartan tablets. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15061735.","journal-title":"Pharmaceutics"},{"key":"1257_CR23","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.ejps.2006.06.006","volume":"29","author":"JJ Sheng","year":"2006","unstructured":"Sheng JJ, Kasim NA, Chandrasekharan R, Amidon GL. Solubilization and dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant. Eur J Pharm Sci. 2006;29:306\u201314. https:\/\/doi.org\/10.1016\/j.ejps.2006.06.006.","journal-title":"Eur J Pharm Sci"},{"key":"1257_CR24","doi-asserted-by":"publisher","first-page":"14278","DOI":"10.1021\/acsomega.1c01035","volume":"6","author":"A Kurotani","year":"2021","unstructured":"Kurotani A, Kakiuchi T, Kikuchi J. Solubility prediction from molecular properties and analytical data using an in-phase deep neural network (Ip-DNN). ACS Omega. 2021;6:14278\u201387. https:\/\/doi.org\/10.1021\/acsomega.1c01035.","journal-title":"ACS Omega"},{"key":"1257_CR25","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s11095-014-1487-z","volume":"32","author":"JH Fagerberg","year":"2015","unstructured":"Fagerberg JH, Karlsson E, Ulander J, Hanisch G, Bergstrom CA. Computational prediction of drug solubility in fasted simulated and aspirated human intestinal fluid. Pharm Res. 2015;32:578\u201389. https:\/\/doi.org\/10.1007\/s11095-014-1487-z.","journal-title":"Pharm Res"},{"key":"1257_CR26","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1021\/acs.molpharmaceut.5c00500","volume":"22","author":"S Steigert","year":"2025","unstructured":"Steigert S, et al. Drug solubility in human colonic fluids and comparison to small intestinal and simulated fluids. Mol Pharm. 2025;22:4855\u201364. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c00500.","journal-title":"Mol Pharm"},{"issue":"Suppl 2","key":"1257_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2165\/00003495-198500292-00004","volume":"29","author":"B Edgar","year":"1985","unstructured":"Edgar B, et al. Absorption, distribution and elimination of felodipine in man. Drugs. 1985;29(Suppl 2):9\u201315. https:\/\/doi.org\/10.2165\/00003495-198500292-00004.","journal-title":"Drugs"},{"key":"1257_CR28","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/s0149-2918(02)80095-9","volume":"24","author":"J Najib","year":"2002","unstructured":"Najib J. Fenofibrate in the treatment of dyslipidemia: a review of the data as they relate to the new suprabioavailable tablet formulation. Clin Ther. 2002;24:2022\u201350. https:\/\/doi.org\/10.1016\/s0149-2918(02)80095-9.","journal-title":"Clin Ther"},{"key":"1257_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/00498250801956350","volume":"38","author":"M Mukoyoshi","year":"2008","unstructured":"Mukoyoshi M, et al. In vitro drug-drug interaction studies with febuxostat, a novel non-purine selective inhibitor of xanthine oxidase: plasma protein binding, identification of metabolic enzymes and cytochrome P450 inhibition. Xenobiotica. 2008;38:496\u2013510. https:\/\/doi.org\/10.1080\/00498250801956350.","journal-title":"Xenobiotica"},{"key":"1257_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2165\/00003088-198510040-00001","volume":"10","author":"U Klotz","year":"1985","unstructured":"Klotz U. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clin Pharmacokinet. 1985;10:285\u2013302. https:\/\/doi.org\/10.2165\/00003088-198510040-00001.","journal-title":"Clin Pharmacokinet"},{"key":"1257_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ijpharm.2016.11.019","volume":"515","author":"M Khoder","year":"2016","unstructured":"Khoder M, et al. Efficient approach to enhance drug solubility by particle engineering of bovine serum albumin. Int J Pharm. 2016;515:740\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.11.019.","journal-title":"Int J Pharm"},{"key":"1257_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16121619","author":"M Batool","year":"2024","unstructured":"Batool M, et al. Clinical pharmacokinetics of fexofenadine: a systematic review. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/pharmaceutics16121619.","journal-title":"Pharmaceutics"},{"key":"1257_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/bcpt.12342","volume":"116","author":"M Boegh","year":"2015","unstructured":"Boegh M, Nielsen HM. Mucus as a barrier to drug delivery - understanding and mimicking the barrier properties. Basic Clin Pharmacol Toxicol. 2015;116:179\u201386. https:\/\/doi.org\/10.1111\/bcpt.12342.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"1257_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ejps.2017.10.003","volume":"111","author":"CM Madsen","year":"2018","unstructured":"Madsen CM, et al. Effect of composition of simulated intestinal media on the solubility of poorly soluble compounds investigated by design of experiments. Eur J Pharm Sci. 2018;111:311\u20139. https:\/\/doi.org\/10.1016\/j.ejps.2017.10.003.","journal-title":"Eur J Pharm Sci"},{"key":"1257_CR35","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1177\/0091270009354995","volume":"50","author":"T Zhu","year":"2010","unstructured":"Zhu T, Ansquer JC, Kelly MT, Sleep DJ, Pradhan RS. Comparison of the gastrointestinal absorption and bioavailability of fenofibrate and fenofibric acid in humans. J Clin Pharmacol. 2010;50:914\u201321. https:\/\/doi.org\/10.1177\/0091270009354995.","journal-title":"J Clin Pharmacol"},{"key":"1257_CR36","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejpb.2023.03.013","volume":"186","author":"C Tannergren","year":"2023","unstructured":"Tannergren C, et al. Physiologically based biopharmaceutics modeling of regional and colon absorption in humans. Eur J Pharm Biopharm. 2023;186:144\u201359. https:\/\/doi.org\/10.1016\/j.ejpb.2023.03.013.","journal-title":"Eur J Pharm Biopharm"},{"key":"1257_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.xphs.2020.09.021","volume":"110","author":"XJH Pepin","year":"2021","unstructured":"Pepin XJH, et al. In vitro biopredictive methods: a workshop summary report. J Pharm Sci. 2021;110:567\u201383. https:\/\/doi.org\/10.1016\/j.xphs.2020.09.021.","journal-title":"J Pharm Sci"},{"key":"1257_CR38","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1194\/jlr.R054114","volume":"56","author":"PA Dawson","year":"2015","unstructured":"Dawson PA, Karpen SJ. Intestinal transport and metabolism of bile acids. J Lipid Res. 2015;56:1085\u201399. https:\/\/doi.org\/10.1194\/jlr.R054114.","journal-title":"J Lipid Res"},{"key":"1257_CR39","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/jcph.1097","volume":"58","author":"W Byon","year":"2018","unstructured":"Byon W, Nepal S, Schuster AE, Shenker A, Frost CE. Regional gastrointestinal absorption of apixaban in healthy subjects. J Clin Pharmacol. 2018;58:965\u201371. https:\/\/doi.org\/10.1002\/jcph.1097.","journal-title":"J Clin Pharmacol"},{"key":"1257_CR40","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1021\/acs.molpharmaceut.7b00286","volume":"14","author":"S Nagar","year":"2017","unstructured":"Nagar S, Korzekwa RC, Korzekwa K. Continuous intestinal absorption model based on the convection-diffusion equation. Mol Pharm. 2017;14:3069\u201386. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00286.","journal-title":"Mol Pharm"},{"key":"1257_CR41","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejps.2013.10.001","volume":"57","author":"C Tannergren","year":"2014","unstructured":"Tannergren C, Borde A, Borestrom C, Abrahamsson B, Lindahl A. Evaluation of an in vitro faecal degradation method for early assessment of the impact of colonic degradation on colonic absorption in humans. Eur J Pharm Sci. 2014;57:200\u20136. https:\/\/doi.org\/10.1016\/j.ejps.2013.10.001.","journal-title":"Eur J Pharm Sci"},{"key":"1257_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5414\/cpp44071","volume":"44","author":"N Petri","year":"2006","unstructured":"Petri N, et al. Effect of erythromycin on the absorption of fexofenadine in the jejunum, ileum and colon determined using local intubation in healthy volunteers. Int J Clin Pharmacol Ther. 2006;44:71\u20139. https:\/\/doi.org\/10.5414\/cpp44071.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1257_CR43","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/BF00608217","volume":"30","author":"AH Staib","year":"1986","unstructured":"Staib AH, Loew D, Harder S, Graul EH, Pfab R. Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled durg delivery device. Eur J Clin Pharmacol. 1986;30:691\u20137. https:\/\/doi.org\/10.1007\/BF00608217.","journal-title":"Eur J Clin Pharmacol"},{"key":"1257_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3109\/21556660.2014.946604","volume":"3","author":"R Teng","year":"2014","unstructured":"Teng R, Maya J. Absolute bioavailability and regional absorption of ticagrelor in healthy volunteers. J Drug Assess. 2014;3:43\u201350. https:\/\/doi.org\/10.3109\/21556660.2014.946604.","journal-title":"J Drug Assess"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01257-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01257-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01257-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:08:33Z","timestamp":1785521313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-026-01257-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1257"],"URL":"https:\/\/doi.org\/10.1208\/s12248-026-01257-4","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"109"}}